Working… Menu

Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma (BiovaxID)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00091676
Recruitment Status : Unknown
Verified February 2012 by Biovest International.
Recruitment status was:  Active, not recruiting
First Posted : September 17, 2004
Last Update Posted : February 3, 2012
Information provided by (Responsible Party):
Biovest International

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2012
Estimated Study Completion Date : December 2012